188 related articles for article (PubMed ID: 9578519)
1. Felbamate: 1997 update.
Pellock JM; Brodie MJ
Epilepsia; 1997 Dec; 38(12):1261-4. PubMed ID: 9578519
[No Abstract] [Full Text] [Related]
2. Taming the brain storms: felbamate updated.
Brodie MJ; Pellock JM
Lancet; 1995 Oct; 346(8980):918-9. PubMed ID: 7564721
[No Abstract] [Full Text] [Related]
3. Felbamate as add-on therapy.
Li LM; Nashef L; Moriarty J; Duncan JS; Sander JW
Eur Neurol; 1996; 36(3):146-8. PubMed ID: 8738944
[TBL] [Abstract][Full Text] [Related]
4. Felbamate: restrictions on use.
Farrington E
Pediatr Nurs; 1995; 21(2):188, 200. PubMed ID: 7746687
[No Abstract] [Full Text] [Related]
5. The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame?
Thakkar K; Billa G; Rane J; Chudasama H; Goswami S; Shah R
Expert Rev Neurother; 2015; 15(12):1373-5. PubMed ID: 26566191
[TBL] [Abstract][Full Text] [Related]
6. Felbamate: new preparation. May benefit multiresistant epileptic patients.
Prescrire Int; 1998 Jun; 7(35):78-81. PubMed ID: 10342924
[TBL] [Abstract][Full Text] [Related]
7. Aplastic anemia in a patient receiving felbamate for complex partial seizures.
Pennell PB; Ogaily MS; Macdonald RL
Neurology; 1995 Mar; 45(3 Pt 1):456-60. PubMed ID: 7898696
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic drug monitoring of felbamate].
Tribut O; Bentué-Ferrer D; Verdier MC;
Therapie; 2010; 65(1):35-8. PubMed ID: 20205993
[TBL] [Abstract][Full Text] [Related]
9. Felbamate.
Pellock JM
Epilepsia; 1999; 40 Suppl 5():S57-62. PubMed ID: 10530695
[TBL] [Abstract][Full Text] [Related]
10. Is there any future for felbamate treatment?
Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ
Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV
Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of case reports of aplastic anemia among patients treated with felbamate.
Kaufman DW; Kelly JP; Anderson T; Harmon DC; Shapiro S
Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520
[TBL] [Abstract][Full Text] [Related]
13. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group.
Avanzini G; Canger R; Dalla Bernardina B; Vigevano F
Epilepsy Res; 1996 Nov; 25(3):249-55. PubMed ID: 8956923
[TBL] [Abstract][Full Text] [Related]
14. Felbamate: clinical and molecular aspects of a unique antiepileptic drug.
Brown WM; Aiken SP
Crit Rev Neurobiol; 1998; 12(3):205-22. PubMed ID: 9847055
[TBL] [Abstract][Full Text] [Related]
15. Felbamate.
Leppik IE
Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
[TBL] [Abstract][Full Text] [Related]
16. Felbamate therapy in the Lennox-Gastaut syndrome.
Snodgrass SR
N Engl J Med; 1993 Jun; 328(22):1641. PubMed ID: 8487814
[No Abstract] [Full Text] [Related]
17. Felbamate.
Bourgeois BF
Semin Pediatr Neurol; 1997 Mar; 4(1):3-8. PubMed ID: 9097361
[TBL] [Abstract][Full Text] [Related]
18. Felbamate.
Sofia RD; Kramer L; Perhach JL; Rosenberg A
Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064
[No Abstract] [Full Text] [Related]
19. Felbamate in epilepsy therapy: evaluating the risks.
Pellock JM
Drug Saf; 1999 Sep; 21(3):225-39. PubMed ID: 10487399
[TBL] [Abstract][Full Text] [Related]
20. 27-year-old woman with pancytopenia.
Rayson D; Kang EM; Inwards DJ
Mayo Clin Proc; 1995 Feb; 70(2):185-8. PubMed ID: 7845045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
